AstraZeneca Prilosec Response To Price Competition Has Eye Toward Nexium

30 Oct 2000

• By The Pink Sheet

AstraZeneca's response to price competition to Prilosec is mindful of the company's plans for the successor product Nexium, AstraZeneca told investors during a quarterly conference call Oct. 25.

AstraZeneca Prilosec Response To Price Competition Has Eye Toward Nexium

More from Archive

More from Pink Sheet